References
- AbrahmPIndiraniKDesigamaniKNitro-argenine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces ibuprofen-induced gastric mucosal injury in the ratDigest Dis Sci20055091632164016133962
- BradburyFHow important is the role of the physician in the correct use of a drug? An observational cohort study in general practiceInt J Clin Prat2004581442732
- ChavezMLDekorteCJValdecoxib: a reviewCin Ther2003253817851
- WahbiAAHassanEHamdyDSpectrophotometric methods for the determination of ibuprofen in tabletsPak J Pharm Sci2005841616380350
- MurthaJLAndoHYSynthesis of the cholesteryl ester prodrugs cholesteryl ibuprofen and cholesteryl flufenamate and their formulation into phospholipids microemulsionsJ Pharm Sci199483122212287830235
- AbbaspourMRSadeghibFGarekaniHADesign and study of ibuprofen disintegrating sustained-release tablets comprising coated pelletsEur J Pharm Biopharm200868374775917977701
- NagpalMMaheshwariDKRakhaPFormulation development and evaluation of alginate microspheres of ibuprofenJ Young Pharm201241131622523454
- BendasERChristensenJMAyresJWDevelopment and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pelletsDrug Dev Ind Pharm201036439340419740039
- AbdullahGZAbdulkarimMFSalmanIMIn vitro permeation and in vivo anti-inflammatory and analgesic properties of nanoscaled emulsions containing ibuprofen for topical deliveryInt J Nanomedicine2011638739621499428
- ZhangMAkbulutMAdsorption, desorption, and removal of polymeric nanomedicine on and from cellulose surfaces: effect of sizeLangmuir20112720125501255921879763
- PottaSGMinemiSNukalaRKPreparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubilityJ Microencapsul2011281748121171818
- PergeLRobitzerMGuillemotCNew solid lipid microparticles for controlled ibuprofen release: formulation and characterization studyInt J Pharm20124221–2596722027394
- GuoCYWangJCaoFLLyotropic liquid crystal systems in drug deliveryDrug Discov Today20101523/241032104020934534
- YangDArmitageBMarderSRCubic liquid-crystalline nanoparticlesAngew Chem Int Ed20044344024409
- KorjamoTHeikkinenATMönkkönenJAnalysis of unstirred water layer in vitro permeability experimentsJ Pharm Sci200998124469447919653267
- YaghmurAGlatterOCharacterization and potential applications of nanostructured aqueous dispersionsAdv Colloid Interface Sci2009147–148333342
- BoydBJKhooSMWhittakerDVA lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poor water soluble drug in ratsInt J Pharm20073401/2526017467935
- NguyenTHHanleyTPorterCJBoydBJNanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administrationJ Control Release201116429438
- SpicerPTProgress in liquid crystalline dispersions: cubosomesCurr Opin Cpll Interface Sci200510274279
- MuLSeowPNgoAStudy on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drugColloid Polym Sci200428315865
- YaghmurALaggnerPZhangSModulation of lipidic nanostructures by designer short peptide surfactantsEur J Pharm Sci20083412934
- LaiJLuYYinZPharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticlesInt J Nanomedicine20105132320161984
- YangZWTanYHChenMWDevelopment of amphotericin B-loaded cubosomes through the solemuls technology for enhancing the oral bioavailabilityAAPS Pharm Sci Tech201223112
- PengXSWenXGPanXDesign and in vitro evaluation of capsaicin transdermal controlled release cubic phase gelsAAPS Pharm Sci Tech201011314041410
- HanKWangZPengXTransarterial chemoembolization using docetaxel-loaded phytantriol cubic phase precursor for the treatment of hepatocellular carcinomaJ Pharm Sci201110062240224721491445
- HanKPanXChenMPhytantriol-based inverted type discontinuous cubic phase for vascular embolization and drug sustained releaseEur J Pharm Sci201041569269920883779
- YangZWPengXSTanYHOptimization of the preparation process for an oral phytantriol-based amphotericin B cubosomesJ Nanomater2011201111021808638
- GustafssonJLjusberg-WahrenHAlmgrenMCubic lipid-water phase dispersed into submicron particlesLangmuir1996122046114613
- ChungHKimJUmJSelf-assembled nanocubicle as a carrier for peroral insulin deliveryDiabetologia200245344845111914752
- ZengNGaoXHuQLipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorptionInt J Nanomedicine201273703371822888230
- PanwarPPandeyBLakheraPPreparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomesInt J Nanomedicine2010510110820309396
- JavadzadehYAhadiFDavaranSPreparation and physicochemical characterization of naproxen-PLGA nanoparticlesColloids Surf B Biointerfaces20108149850220719477
- TanakaNImaiNOkimotoKDevelopment of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipineJ Control Release20051082–338639616253377
- FengSSMuLWinKYNanoparticles of biodegradable polymers for clinical administration of paclitaxelCurr Med Chem200411441342414965222
- FengSSMeiLAnithaPPoly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxeBiomaterials200930193297330619299012
- MittalGSahanaDBhardwajVEstradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivoJ Control Release20071191778517349712
- DesaiMPLabhasetwarVAmidonGLGastrointestinal uptake of biodegradable microparticles: effect of particle sizePharm Res199613183818458987081
- CostanzoPJPattenTESeeryTANanoparticle agglutination: acceleration of aggregation rates and broadening of the analyte concentration range using mixtures of various-sized nanoparticlesLangmuir20062262788279416519483
- ShahJCSadhaleYChilukuriDMCubic phase gels as drug delivery systemsAdv Drug Delive Rev2001472–3229250
- ThomsonABSchoellerCKeelanMLipid absorption: passing through the unstirred layers, brush-border membrane, and beyondCan J Physiol Pharmacol19937185315558306192
- KatneniKCharmanSAPorterCJAn evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicityJ Pharm Pharmacol200860101311131918812024